Literature DB >> 8607863

Endothelin-1 induces increased fibronectin expression in human bronchial epithelial cells.

M Marini1, S Carpi, A Bellini, F Patalano, S Mattoli.   

Abstract

Endothelin-1 may be involved in the pathogenesis of asthma by causing bronchial smooth muscle constriction and airway remodelling. Bronchial epithelial cells represent an important source of endothelin-1 in this disease, and increased release of epithelial cell-derived endothelin-1 may contribute to the genesis of subepithelial fibrosis by promoting fibroblast proliferation and collagen production. In this study, we demonstrate that endothelin-1 upregulates fibronectin gene expression and fibronectin release in bronchial epithelial cells via an ETA receptor. Fibronectin is an important component of the extracellular matrix which is deposited in excess in the subepithelial area of asthmatic bronchial mucosa, and it represents a potent chemotactic factor for fibroblasts. Thus, endothelin-1 may induce subepithelial fibrosis both directly and by the autocrine mechanism reported here.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8607863     DOI: 10.1006/bbrc.1996.0502

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Targeting Fibronectin for Cancer Imaging and Therapy.

Authors:  Zheng Han; Zheng-Rong Lu
Journal:  J Mater Chem B       Date:  2016-12-01       Impact factor: 6.331

2.  LU135252, an endothelin(A) receptor antagonist did not prevent pulmonary vascular remodelling or lung fibrosis in a rat model of myocardial infarction.

Authors:  Q T Nguyen; F Colombo; J L Rouleau; J Dupuis; A Calderone
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

3.  Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease.

Authors:  D J Abraham; R Vancheeswaran; M R Dashwood; V S Rajkumar; P Pantelides; S W Xu; R M du Bois; C M Black
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

Review 4.  Endothelial dysfunction and atherosclerosis: endothelin receptor antagonists as novel therapeutics.

Authors:  M Barton
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 4.592

5.  Increased endothelin-1 levels of BAL fluid in patients with Behçet's disease.

Authors:  Kamel Hamzaoui; Hanene Chelbi; Mariam Kamoun; Imen Ben Dhifallah; Agnes Hamzaoui
Journal:  Mediators Inflamm       Date:  2007-03-19       Impact factor: 4.711

Review 6.  Role of endothelin-1 in lung disease.

Authors:  K A Fagan; I F McMurtry; D M Rodman
Journal:  Respir Res       Date:  2001-02-22

Review 7.  Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives.

Authors:  Scott D Collum; Javier Amione-Guerra; Ana S Cruz-Solbes; Amara DiFrancesco; Adriana M Hernandez; Ankit Hanmandlu; Keith Youker; Ashrith Guha; Harry Karmouty-Quintana
Journal:  Can Respir J       Date:  2017-02-13       Impact factor: 2.409

8.  Endothelin-1 mediates Aspergillus fumigatus-induced airway inflammation and remodelling.

Authors:  Briony Labram; Sara Namvar; Tracy Hussell; Sarah E Herrick
Journal:  Clin Exp Allergy       Date:  2019-03-18       Impact factor: 5.018

9.  Endothelin-1 Serum Concentration in Pediatric Chronic Idiopathic Uveitis.

Authors:  Katarzyna Powierza; Jolanta Sawicka-Powierza; Beata Urban; Beata Żelazowska-Rutkowska; Bogdan Cylwik; Bożena Mikołuć; Olga Kowalewska; Alina Bakunowicz-Łazarczyk
Journal:  Clin Ophthalmol       Date:  2021-01-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.